List of JCR Pharmaceuticals patents

Patents where

Current Assignee

Name

JCR Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7402150 Injection device	Patent 7402150 was granted and assigned to JCR Pharmaceuticals on July, 2008 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	7402150	July 22, 2008
‌ US Patent 9279109 Method for production of recombinant human iduronate 2-sulfatase	Patent 9279109 was granted and assigned to JCR Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	9279109	March 8, 2016
‌ US Patent 9994641 Anti-human transferrin receptor antibody that passes through blood-brain barrier	Patent 9994641 was granted and assigned to JCR Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	9994641	June 12, 2018
‌ US Patent 9657310 Expression vector	Patent 9657310 was granted and assigned to JCR Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	9657310	May 23, 2017
‌ US Patent 11248045 Anti-human transferrin receptor antibody permeating blood-brain barrier	Patent 11248045 was granted and assigned to JCR Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	11248045	February 15, 2022
‌ US Patent 7235253 Powder containing physiologically active peptide	Patent 7235253 was granted and assigned to JCR Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	7235253	June 26, 2007
‌ US Patent 10940185 Lyophilized preparation	Patent 10940185 was granted and assigned to JCR Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10940185	March 9, 2021
‌ US Patent 9617529 Method for production of recombinant human alpha-galactosidase A	Patent 9617529 was granted and assigned to JCR Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	9617529	April 11, 2017
‌ US Patent 10385325 Method for production of recombinant human alpha-galactosidase A from material containing contaminant host cell proteins by chromatography	Patent 10385325 was granted and assigned to JCR Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10385325	August 20, 2019
‌ US Patent 11046751 Human serum albumin mutant	Patent 11046751 was granted and assigned to JCR Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	11046751	June 29, 2021
‌ US Patent 8465733 Pharmaceutical composition containing human mesenchymal stem cell	Patent 8465733 was granted and assigned to JCR Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	8465733	June 18, 2013
‌ US Patent 7939296 Method for production of recombinant human FSH	Patent 7939296 was granted and assigned to JCR Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	7939296	May 10, 2011
‌ US Patent 8685691 Method for producing aminopeptidase	Patent 8685691 was granted and assigned to JCR Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	8685691	April 1, 2014
‌ US Patent 10968267 Serum albumin-20K growth hormone fusion protein	Patent 10968267 was granted and assigned to JCR Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10968267	April 6, 2021
‌ US Patent 8759288 Blastocyst culture supernatant as a fertility agent in blastocyst transfer	Patent 8759288 was granted and assigned to JCR Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	8759288	June 24, 2014
‌ US Patent 9896715 Method for analyzing formyl glycine residue	Patent 9896715 was granted and assigned to JCR Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	9896715	February 20, 2018
‌ US Patent 8673648 Sugar analysis device and analysis method	Patent 8673648 was granted and assigned to JCR Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	8673648	March 18, 2014
‌ US Patent 8348902 Syringe holder and injection device	Patent 8348902 was granted and assigned to JCR Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	8348902	January 8, 2013
‌ US Patent 11078293 Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier	Patent 11078293 was granted and assigned to JCR Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	11078293	August 3, 2021
‌ US Patent 10759864 Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier	Patent 10759864 was granted and assigned to JCR Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10759864	September 1, 2020
‌ US Patent 7534222 Injection device	Patent 7534222 was granted and assigned to JCR Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		JCR Pharmaceuticals	United States Patent and Trademark Office	7534222	May 19, 2009
‌ US Patent 10041039 Method for producing pluripotent stem cells derived from dental pulp	Patent 10041039 was granted and assigned to JCR Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10041039	August 7, 2018
‌ US Patent 10654912 Human serum albumin mutant		JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10654912	May 19, 2020
‌ US Patent 10858640 Production for recombinant human DNase I	Patent 10858640 was granted and assigned to JCR Pharmaceuticals on December, 2020 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10858640	December 8, 2020
‌ US Patent 10273448 Medium containing uridine and N-acetyl-D-mannosamine	Patent 10273448 was granted and assigned to JCR Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	JCR Pharmaceuticals	JCR Pharmaceuticals	United States Patent and Trademark Office	10273448	April 30, 2019

Results per page:

30 results

0 selected

30 results

0 selected